Hawkins, Inc. (HWKN) - 10-K Summary
Business Context and Reporting Period
Company: Hawkins, Inc.
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: March 30, 2025
Business Overview: Hawkins is a leading water treatment and specialty ingredients company operating in three segments: Water Treatment, Industrial, and Health and Nutrition. The company formulates, manufactures, distributes, and blends products for municipal, industrial, and consumer markets.
Key Financial Metrics (Fiscal 2025)
| Metric | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Total Sales | $974.4 million | $919.2 million |
| Gross Profit | $225.5 million (23.1% margin) | $193.6 million (21.1% margin) |
| Operating Income | $119.2 million (12.2% margin) | $104.0 million (11.3% margin) |
| Net Income | $84.3 million | $75.4 million |
| Diluted EPS | $4.03 | $3.59 |
| Operating Cash Flow | $111.1 million | $159.5 million |
| Debt Outstanding (Revolving) | $149.0 million | $99.0 million |
| Cash and Equivalents | $5.1 million | $7.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 6% ($55.2 million) driven primarily by the Water Treatment segment, which grew 23% due to acquisitions and organic volume growth. Conversely, the Industrial segment declined 7% due to lower selling prices and product mix changes, while Health and Nutrition remained flat.
- Profitability: Gross profit margin expanded from 21.1% to 23.1%. This improvement was aided by a favorable LIFO reserve adjustment of $1.6 million and the absence of a $7.7 million environmental charge recorded in the prior year.
- Acquisitions: The company completed four acquisitions in fiscal 2025 (Amerochem, Waterguard, Wofford, Intercoastal) contributing approximately $67 million in annualized revenue and $72 million in actual sales for the period.
- Working Capital: Operating cash flow decreased significantly ($48.4 million) compared to the prior year, primarily due to increased customer receivables and higher inventory levels associated with sales growth and seasonal bulk chemical purchases.
Guidance, Outlook, and Risks
- Subsequent Events: On April 25, 2025, the company acquired WaterSurplus for approximately $150 million (plus potential earnouts) and amended its credit facility to increase capacity to $400 million.
- Segment Realignment: Effective fiscal 2026, the company will realign reporting segments to Water Treatment, Health and Food Sciences, and Industrial Solutions.
- Capital Allocation: The company repurchased 205,943 shares for $20.7 million and paid $14.6 million in dividends. Capital expenditures were $41.1 million, with an anticipated $60 million for fiscal 2026.
- Key Risks:
- Commodity Volatility: Fluctuations in raw material prices (e.g., caustic soda) can impact margins, though the company attempts to pass costs to customers.
- Supply Chain: Reliance on third-party transportation (rail, barge, truck) exposes the company to disruptions and cost increases.
- Regulatory: Subject to strict environmental, health, and safety regulations (EPA, FDA, DOT) which could increase compliance costs or limit operations.
- Seasonality: Water Treatment and Agricultural sales are seasonal, typically peaking in the second half of the fiscal year.
Investor Verification Checklist
- Acquisition Integration: Verify the integration progress and revenue contribution of the four fiscal 2025 acquisitions and the subsequent WaterSurplus deal.
- Debt Covenants: Confirm continued compliance with the fixed charge coverage ratio (min 1.15:1) and leverage ratio (max 3.5:1) under the amended $400 million credit facility.
- Environmental Liabilities: Monitor the $7.7 million remediation liability for PCBs at the Rosemount, MN facility for any cost overruns.
- Raw Material Pricing: Assess the company's ability to pass through rising commodity costs to customers without volume erosion.
- Working Capital Trends: Track receivables and inventory levels to ensure they align with sales growth and do not signal collection or obsolescence issues.